Santhera Pharmaceuticals (SIX: SANN)

Last close As at 08/01/2026

CHF13.58

1.34 (10.95%)

Market capitalisation

CHF191m

Santhera Pharmaceuticals (SIX: SANN) is a Swiss specialty pharmaceutical company focused on the development and commercialization of innovative medicines for rare neuromuscular diseases with high unmet medical need.

Latest Insights

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash, CFA

Director, healthcare

Key Management

  • Dario Eklund

    CEO

  • Catherine Isted

    CFO